首页> 外文期刊>Stem Cells >Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease.
【24h】

Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease.

机译:在视网膜疾病的啮齿动物模型中,从脐带组织分离出的细胞拯救了感光器和视觉功能。

获取原文
获取原文并翻译 | 示例
           

摘要

Progressive photoreceptor degeneration resulting from genetic and other factors is a leading and largely untreatable cause of blindness worldwide. The object of this study was to find a cell type that is effective in slowing the progress of such degeneration in an animal model of human retinal disease, is safe, and could be generated in sufficient numbers for clinical application. We have compared efficacy of four human-derived cell types in preserving photoreceptor integrity and visual functions after injection into the subretinal space of the Royal College of Surgeons rat early in the progress of degeneration. Umbilical tissue-derived cells, placenta-derived cells, and mesenchymal stem cells were studied; dermal fibroblasts served as cell controls. At various ages up to 100 days, electroretinogram responses, spatial acuity, and luminance threshold were measured. Both umbilical-derived and mesenchymal cells significantly reduced the degree of functional deterioration in each test. The effect of placental cells was not much better than controls. Umbilical tissue-derived cells gave large areas of photoreceptor rescue; mesenchymal stem cells gave only localized rescue. Fibroblasts gave sham levels of rescue. Donor cells were confined to the subretinal space. There was no evidence of cell differentiation into neurons, of tumor formation or other untoward pathology. Since the umbilical tissue-derived cells demonstrated the best photoreceptor rescue and, unlike mesenchymal stem cells, were capable of sustained population doublings without karyotypic changes, it is proposed that they may provide utility as a cell source for the treatment of retinal degenerative diseases such as retinitis pigmentosa.
机译:由遗传和其他因素引起的进行性光感受器变性是全球范围内导致失明的主要原因,并且在很大程度上无法治愈。这项研究的目的是找到一种能有效减缓人类视网膜疾病动物模型中此类变性进程的细胞类型,并且这种细胞类型安全并且可以为临床应用产生足够数量的细胞。我们已经比较了四种人源细胞类型在退化的早期阶段注入皇家外科医学院大鼠视网膜下空间后保持光感受器完整性和视觉功能的功效。研究了脐带组织来源的细胞,胎盘来源的细胞和间充质干细胞。真皮成纤维细胞用作细胞对照。在长达100天的各个年龄段,测量视网膜电图反应,空间敏锐度和亮度阈值。在每次测试中,脐带来源的细胞和间充质细胞均显着降低了功能恶化的程度。胎盘细胞的作用并不比对照组好。脐带组织来源的细胞可拯救大面积的感光细胞。间充质干细胞仅提供局部拯救。成纤维细胞可达到假手术的程度。供体细胞被限制在视网膜下空间。没有证据表明细胞分化为神经元,肿瘤形成或其他不良病理。由于脐带组织来源的细胞表现出最佳的感光细胞拯救能力,并且与间充质干细胞不同,能够持续增加群体数量而不会发生核型改变,因此建议将它们作为治疗视网膜退行性疾病如色素性视网膜炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号